Ocular Oncology Service, Wills Eye Institute, Thomas Jefferson University, Philadelphia, Pennsylvania.
Am J Ophthalmol. 2013 Oct;156(4):825-9. doi: 10.1016/j.ajo.2013.05.023. Epub 2013 Jul 20.
To report on the frequency of cysts and tumors of the pineal gland in patients with retinoblastoma.
Observational retrospective case control study.
Institutional. study population: Four hundred eight patients treated for retinoblastoma from January 2000 to January 2012 at Wills Eye Institute, Philadelphia, Pennsylvania, USA.
Magnetic resonance imaging (MRI) features of the pineal gland were evaluated in all patients with retinoblastoma. Characteristics of patients with pineal cysts and pineoblastoma were reviewed.
Comparison of frequency of pineal gland cyst and pineoblastoma in children managed with systemic chemoreduction vs other methods.
Of 408 patients, treatment included systemic chemoreduction in 252 (62%) and nonchemoreduction methods in 156 (38%). Overall, 34 patients (8%) manifested pineal gland cyst and 4 (1%) showed pineoblastoma. Of all 408 patients, comparison (chemoreduction vs nonchemoreduction) revealed pineal cyst (20/252 vs 14/156, P = .7) and pineoblastoma (1/252 vs 3/156, P = .1). The pineal cyst (n = 34) (mean diameter 4 mm) was asymptomatic (n = 34), followed conservatively (n = 34), and with minimal enlargement (n = 2, 9%) but without progression to pineoblastoma. The cyst was found in 22 germline and 12 nongermline patients (P = .15). Among the 4 patients with pineoblastoma, all had germline mutation and 2 had family history of retinoblastoma. Among all patients with family history of retinoblastoma (n = 45), 2 (4%) developed pineoblastoma. The pineoblastoma was asymptomatic in 2 patients and symptomatic with vomiting and headache in 2 patients. The mean interval from date of retinoblastoma detection to pineal cyst was 2 months (median 2, range 0-8 months) and to pineoblastoma was 27 months (median 28, range 7-46 months). Management included aggressive chemotherapy and radiotherapy, with 2 survivors.
Pineal gland cyst was incidentally detected in 8% of retinoblastoma patients, causing no symptoms, and without progression to pineoblastoma. Pineoblastoma was detected in 1% of patients and fewer patients who received systemic chemotherapy developed pineoblastoma, possibly indicating a systemic protective effect.
报告视网膜母细胞瘤患者松果体囊肿和肿瘤的发生率。
观察性回顾性病例对照研究。
机构。研究人群:2000 年 1 月至 2012 年 1 月期间,在美国宾夕法尼亚州费城威尔斯眼研究所接受治疗的 408 例视网膜母细胞瘤患者。
对所有接受视网膜母细胞瘤治疗的患者进行磁共振成像(MRI)松果体特征评估。回顾了松果体囊肿和松果体母细胞瘤患者的特征。
比较接受全身化疗与其他方法治疗的儿童松果体囊肿和松果体母细胞瘤的发生率。
408 例患者中,252 例(62%)接受全身化疗,156 例(38%)接受非化疗方法治疗。总体而言,34 例(8%)患者表现为松果体囊肿,4 例(1%)患者表现为松果体母细胞瘤。在所有 408 例患者中,比较(化疗与非化疗)发现松果体囊肿(20/252 与 14/156,P =.7)和松果体母细胞瘤(1/252 与 3/156,P =.1)。松果体囊肿(n = 34)(平均直径 4 毫米)无症状(n = 34),保守治疗(n = 34),仅有轻微增大(n = 2,9%),但无进展为松果体母细胞瘤。囊肿见于 22 例种系和 12 例非种系患者(P =.15)。在 4 例松果体母细胞瘤患者中,均存在种系突变,2 例有视网膜母细胞瘤家族史。在所有有视网膜母细胞瘤家族史的患者(n = 45)中,有 2 例(4%)发生松果体母细胞瘤。2 例患者无症状,2 例患者有呕吐和头痛症状。从发现视网膜母细胞瘤到松果体囊肿的平均间隔为 2 个月(中位数 2,范围 0-8 个月),到松果体母细胞瘤的平均间隔为 27 个月(中位数 28,范围 7-46 个月)。治疗包括积极的化疗和放疗,2 例患者存活。
视网膜母细胞瘤患者松果体囊肿的发生率为 8%,无症状,无进展为松果体母细胞瘤。松果体母细胞瘤的检出率为 1%,接受全身化疗的患者较少发生松果体母细胞瘤,这可能表明全身化疗具有保护作用。